Europe
Asia
Oceania
Americas
Africa
FORTUNE OCTOBER/NOVEMBER 2023 63
59 COMPANIES
CITY
In rude health: AstraZeneca, Britain’s biggest drugmaker, has “risen to the challenge” of US healthcare providers negotiating drug prices by posting “solid first-half sales growth”, says Derren Nathan
Our expert astrologer Lucy Lam reveals what your month has in store for you...
Companies in the news and how they were assessed
UK equities are having their time in the sun. The FTSE 100 recently hit an all-time high of 9,000, driven by a broad recovery in equity prices. To put it another way, the rally wasn’t just driven by a
Out of puff: Second-quarter revenue at Connecticut-based Marlboro-maker Philip Morris International (PMI) rose 7.1% from a year earlier, to $10.1bn – slightly short of analysts’ expectations of $10.3b